Table of Contents

July 1, 2023; Volume 64,Issue 7

  1. Vanbrocklin, Henry F.

    1. Evaluation of <sup>134</sup>Ce/<sup>134</sup>La as a PET Imaging Theranostic Pair for <sup>225</sup>Ac α-Radiotherapeutics
      Open Access
      Evaluation of 134Ce/134La as a PET Imaging Theranostic Pair for 225Ac α-Radiotherapeutics
      Kondapa Naidu Bobba, Anil P. Bidkar, Niranjan Meher, Cyril Fong, Anju Wadhwa, Suchi Dhrona, Alex Sorlin, Scott Bidlingmaier, Becka Shuere, Jiang He, David M. Wilson, Bin Liu, Youngho Seo, Henry F. VanBrocklin and Robert R. Flavell
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1076-1082; DOI: https://doi.org/10.2967/jnumed.122.265355

  2. Varasteh, Zohreh

    1. Regression of Myocardial <sup>99m</sup>Tc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin Amyloidosis
      Regression of Myocardial 99mTc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin Amyloidosis
      Maria Papathanasiou, Lukas Kessler, Frank M. Bengel, Aiste-Monika Jakstaite, David Kersting, Zohreh Varasteh, Peter Luedike, Alexander Carpinteiro, Ken Herrmann, Tienush Rassaf and Christoph Rischpler
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1083-1086; DOI: https://doi.org/10.2967/jnumed.122.265352

  3. Veronesi, Michael C.

    1. Hybrid <sup>18</sup>F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases
      Open Access
      Hybrid 18F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases
      Nathaniel J. Smith, Tristan K. Deaton, Wendy Territo, Brian Graner, Andrew Gauger, Scott E. Snyder, Michael L. Schulte, Mark A. Green, Gary D. Hutchins and Michael C. Veronesi
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1087-1092; DOI: https://doi.org/10.2967/jnumed.122.265149

  4. Vincent-salomon, Anne

    1. Clinical Potential of HER2 PET as a Predictive Biomarker to Guide the Use of Trastuzumab Deruxtecan in Breast Cancer Patients
      Romain-David Seban, Laurence Champion, Audrey Bellesoeur, Anne Vincent-Salomon and Francois-Clement Bidard
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1164-1165; DOI: https://doi.org/10.2967/jnumed.123.265434
Back to top

In this issue